AdvaMed lauds user fee return, new funding for FDA

AdvaMed lauds user fee return, new funding for FDA-massdevice: MASSDEVICE ON CALL — Medtech industry lobbying group AdvaMed offered high praise for the federal government's 2014 omnibus appropriations legislation, which restored important funding for the FDA. The bill returned to the agency about $85 million in collected user fees that had been locked away due to the federal sequester, funds that medical device and drug companies pay for applications for FDA review.